US academic drug discovery
- 1 June 2011
- journal article
- Published by Springer Science and Business Media LLC in Nature Reviews Drug Discovery
- Vol. 10 (6), 409-410
- https://doi.org/10.1038/nrd3462
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- The Role of Public-Sector Research in the Discovery of Drugs and VaccinesNew England Journal of Medicine, 2011
- Integration of Small-Molecule Discovery in Academic Biomedical ResearchMount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2010
- How to improve R&D productivity: the pharmaceutical industry's grand challengeNature Reviews Drug Discovery, 2010
- Lessons from 60 years of pharmaceutical innovationNature Reviews Drug Discovery, 2009
- The Emerging Academic Drug-Discovery SectorFuture Medicinal Chemistry, 2009
- Open access chemical and clinical probes to support drug discoveryNature Chemical Biology, 2009
- Drug discovery in jeopardyJCI Insight, 2006
- Academia–industry partnerships in drug discoveryExpert Opinion on Drug Discovery, 2006
- Small molecules: the missing link in the central dogmaNature Chemical Biology, 2005
- The druggable genomeNature Reviews Drug Discovery, 2002